Stock Financial Ratios

THLD / Threshold Pharmaceuticals, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)9.68
Enterprise Value ($M)22.15
Book Value ($M)19.89
Book Value / Share0.28
Price / Book0.11
NCAV ($M)21.67
NCAV / Share0.30
Price / NCAV0.11
Income Statement (mra) ($M)
Net Income-24.09
Balance Sheet (mrq) ($M)
Cash & Equivalents68.18
Cash / Share0.95
Quick Ratio9.24
Current Ratio9.24
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-1.21
Return on Assets (ROA)-0.99
Return on Equity (ROE)-1.21
Identifiers and Descriptors
Central Index Key (CIK)1183765
Industry Groups
SIC 2834 - Pharmaceutical Preparations
Other Related CUSIPS
Share Statistics
Common Shares Outstanding (M)26.90
Scoring Models
Piotroski F Score1.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Cash Per Share0.95
Inventory Work In Progress Per Share0.00
Current Portion Of Long Term Debt Per Share0.03
Liabilities And Stock Equity Per Share1.43
Debt Per Share0.06
Treasury Stock Per Share0.00
Additional Paid In Capital Per Share2.03
Intangibles Per Share0.02
Deferred Income Tax Liabilities Per Share0.00
Retained Earnings Per Share-0.80
Property Plant And Equipment Per Share0.01
Assets Other Non Current Per Share0.00
Liabilities Other Non Current Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Equity Per Share1.23
Liabilities Per Share0.20
Long Term Debt Per Share0.02
Liabilities Current Per Share0.16
Minority Interest Per Share0.00
Assets Current Per Share0.97
Property Plant And Equipment Gross Per Share0.00
Cash And Equivalents Per Share0.95
Accounts Receivable Per Share0.00
Inventory Raw Materials Per Share0.00
Goodwill Per Share0.05
Assets Other Current Per Share0.00
Accounts Payable Per Share0.00
Inventory Finished Goods Per Share0.00
Property Plant And Equipment Net Per Share0.01
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Inventory Per Share0.00
Assets Per Share1.43

Related News Stories

La Jolla: Red Flags And A Vastly Overestimated Market Create A Compelling Short

2017-11-16 seekingalpha
The market potential for La Jolla's primary asset, a treatment for hypo-tension in Septic Shock patients, is severely overestimated in my opinion. (250-1)

BRIEF-Threshold Pharmaceuticals qtrly earnings per share $0.02

2017-07-31 reuters
* Threshold Pharmaceuticals Inc qtrly earnings per share $0.02 Source text for Eikon: Further company coverage:

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Threshold Pharmaceuticals, Inc. - THLD

2017-05-23 prnewswire
NEW YORK, May 18, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Threshold Pharmaceuticals, Inc. ("Threshold Pharmaceuticals" or the "Company") (NASDAQGM: THLD) relating to the sale of the Company to affiliates of Molecular Templates, Inc. As a result of the merger, Threshold Pharmaceuticals shareholders are only anticipated to own approximately 34.

CUSIP: 885807206